Tirzepatide, semaglutide, and liraglutide lead to weight loss in adults with obesity and T1D over 1 year; the greatest weight loss and a modest decrease in A1c levels are seen with tirzepatide.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1-receptor-agonists-effective-weight-loss-type-1-2025a1000w65?src=rss
Author :
Publish date : 2025-11-19 04:59:00
Copyright for syndicated content belongs to the linked Source.
